PAVM

PAVmed Inc. (PAVM) ESG Analysis Analysis (2026)

Invetso Score: 5.5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.4 (Moderate)

PAVM’s very high R&D intensity versus revenue suggests a science-led model, but peers in life sciences often show similarly elevated development spending.

Negative gross margin indicates resource inefficiency relative to profitable peers, yet this is common in pre-commercial biotech and not uniquely disadvantageous.

Low leverage and net cash reduce balance-sheet pressure, which can support longer-duration environmental investments more comfortably than more indebted peers.

No filing-based evidence provided on emissions, energy use, or waste management limits a stronger peer-relative environmental assessment.

Social

Score:

Extremely high stock-based compensation relative to revenue can align talent retention, but it also signals heavy dilution pressure versus better-balanced peers.

High R&D dependence implies reliance on specialized scientific labor, making workforce continuity material, though this is broadly comparable across biotech peers.

Negative gross margin and early-stage economics can constrain resources for broader employee or community programs relative to more mature peers.

No disclosed data here on safety, diversity, patient access, or labor practices prevents evidence of a stronger social position versus peers.

Governance

Score:

Low leverage and net cash indicate conservative capital structure, but governance quality cannot be inferred without board, audit, or disclosure evidence.

Very high stock-based compensation relative to revenue raises dilution and incentive-design concerns versus peers with tighter compensation discipline.

Heavy R&D spending suggests management prioritizes pipeline development, yet peer comparison requires filing evidence on oversight, controls, and capital allocation.

Absent filing data on board independence, related-party transactions, and shareholder rights, governance positioning remains only average versus peers.

Overall Score

Score:

PAVM appears broadly average versus peers because conservative leverage is offset by weak profitability and limited disclosure on core ESG governance and operating practices.

Score Driver: Limited Disclosure On Material ESG Controls And Practices

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on PAVmed Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →